Navigation Links
Opportunities for Funding US-Israel Cooperation in Innovative Technologies
Date:7/27/2011

TEL AVIV, Israel, July 27, 2011 /PRNewswire/ --

 

The Next Call for Proposals has Been Issued by the BIRD Foundation. Relevant R&D Topics Include but not Limited to: Life Sciences, Cleantech, Communications, Electronics, Software, HLS, etc.

The BIRD Foundation announced its next funding cycle with a call for US-Israel joint project proposals focusing on innovative R&D collaborations between US and Israeli companies. To be considered, a proposal should have significant commercial potential.

The maximum conditional grant per project is up to 50% of the R&D costs associated with the joint project, and no more than $1 million per project.

The application process is web-based and requires prior discussion with the BIRD Foundation.  Executive Summaries are due by Thursday, September 15, 2011. Final full scale proposals are due by Thursday, October 26, 2011. Decisions will be announced by mid December, 2011. Please refer to BIRD's website for submission details - http://www.birdf.com.

Examples of successful BIRD-funded projects include:

ReWalk - Helping Paraplegics to Walk: With support from the BIRD Foundation, Argo Medical Technologies and Allied Orthotics & Prosthetics are working together to develop the ReWalk device that allows a paralyzed patient to "walk" again.

Mobile Travel Tool: MobiMate, a provider of mobile travel services, partnered with Conducive Technology, to develop its newest mobile travel tool, WorldMate Live which predicts travel conflicts for road warriors and automatically provides solutions, often before a traveler even knows there is a potential problem.

New Drug for Gout: KRYSTEXXA(TM) (pegloticase), a PEGylated uric acid specific enzyme indicated for the treatment of chronic gout in adult patients that are refractory to conventional therapy. The drug has been developed by Mountain View Pharmaceuticals, and Bio-technology General (acquired by Savient Pharmaceuticals) and approved by the U.S. Food and Drug Administration.

About the BIRD Foundation

The BIRD (Binational Industrial Research and Development) Foundation works to encourage cooperation between Israeli and American companies in the various areas of technology, and provides free assistance in locating strategic partners from both countries for developing joint products. During its 34 years, the BIRD Foundation has invested in more than 820 projects, which have yielded direct and indirect revenues of about $8 billion.

The BIRD Foundation supports projects without receiving any rights in the participating companies or in the project itself. The financial assistance is repaid as royalties from sales. The Foundation provides support of up to 50% of a project's budget, beginning with R&D and ending with the initial stages of sales and marketing. The Foundation shares the risk and does not demand that the investment be repaid if the project fails to reach the sales stage.

The BIRD Foundation works in full cooperation with the Chief Scientist's Office at the Ministry of Industry, Trade, and Labor in Israel, and with the U.S. Commerce Department's National Institute of Standards and Technology (NIST).

For further inquiries:
Palo Alto, CA - Michal Miasnik, West Coast Representative
Tel: +1-408-398-1288 / michalm@birdf.com
Princeton, NJ - Andrea Yonah East, Coast Representative
Tel: +1-609-356-0305 / andreay@birdf.com

http://www.birdf.com



'/>"/>
SOURCE The BIRD Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Medical Devices Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Marketing Spend and Sales Strategies
2. Maximizing Pharmaceutical Licensing Opportunities
3. Global Pharmaceutical Industry Outlook Survey 2011-2012: Industry Dynamics, Market Trends and Opportunities, Buyer Spend and Procurement Strategies
4. Reportlinker Adds Global Microbiology Testing Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
5. Reportlinker Adds Global Hemostasis Diagnostics Market: US, Europe, Japan--Emerging Opportunities and Business Expansion Strategies for Suppliers
6. Reportlinker Adds Global Nucleic Acid Testing Market--New Product Development Opportunities and Business Expansion Strategies For Instrument and Reagent Suppliers
7. Reportlinker Adds Transfusion Diagnostic Testing Market: US, Europe, Japan--Emerging Opportunities And Business Expansion Strategies for Suppliers
8. Thomson Reuters Trademark Report Reveals New Challenges and Opportunities for Pharmaceutical Brands
9. 2011 Retail Clinician Education Congress to Offer Exclusive Accreditation and Networking Opportunities for Retail Healthcare Professionals
10. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
11. Reportlinker Adds United Arab Emirates Neurology Devices Investment Opportunities, Analysis and Forecasts to 2017
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... SAN FRANCISCO , Feb. 11, 2016 Potrero ... system, is pleased to announce the appointment of George ... San Antonio, TX , WellMed is ... servicing over 200,000 patients and HMO members in ... founding WellMed in 1990 out of his own internal medicine ...
(Date:2/11/2016)... Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... amniotic membrane and other birth tissues, human skin and ... and market advanced products and therapies, announced today that ... Global Healthcare Conference in New York ... Michael J. Senken , Chief Financial Officer and ...
(Date:2/11/2016)...  AfterPill.com is reporting that this week,s Centers for ... women who are at risk of unintended pregnancy impacts ... raises the risks of unprotected sex in particular.  ... to the Guttmacher Institute, there are 43 million women ... who have sex without the intention of becoming pregnant.  ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... According to an article published February ... loss dietary supplement, is being recalled due to the discovery that it contains dangerous ... not a single supplement on the market proven to help people safety lose excess ...
(Date:2/11/2016)... , ... February 11, 2016 , ... Registered nurses, licensed ... CEU seminar titled, “Stroke Management: Time to Act, Time to Heal” on Thursday, February ... in Whippany, N.J. The presenter is Vishal Chedda, president of ANSA Consultants, who will ...
(Date:2/11/2016)... (PRWEB) , ... February 12, 2016 , ... The ... is up from 0.416 in 2013. The SJR uses data taken from the Scopus ... account both the number of citations received by the journal over a three year ...
(Date:2/11/2016)... ... 11, 2016 , ... The Chartis Group, a national advisory ... in the “2015/2016 Best in KLAS: Software and Services” report in two categories: ... and insights firm on a global mission to improve healthcare delivery by amplifying ...
(Date:2/11/2016)... ... February 11, 2016 , ... Thermi™, a world leader ... to announce the promotions of Allison Kelly to executive vice president of the ... vice president of North American capital sales, and Wendy Oseas to vice president ...
Breaking Medicine News(10 mins):